Norozi Vadood, Ghazi Ahmad, Amani Firouz, Bakhshpoori Parya
Ardabil University of Medical Sciences, Fatemi Hospital, Ardabil, Iran.
Ardabil University of Medical Sciences, Emam Reza Hospital, Ardabil, Iran.
Anesth Pain Med. 2021 Aug 8;11(3):e113909. doi: 10.5812/aapm.113909. eCollection 2021 Jun.
The proper management of postoperative pain improves patients' quality of life, accelerates early postoperative recovery, shortens hospitalization period, and reduces medical costs. This study aimed to compare the effectiveness of intravenous fentanyl pump and sublingual buprenorphine tablet in controlling pain after open cholecystectomy.
Evaluating the effectiveness of sublingual buprenorphine in reducing postoperative pain and complications after open cholecystectomy.
This study was a double-blind, randomized clinical trial. The study population encompassed those candidates undergoing open cholecystectomy, patients with ASA class I and II, individuals undergoing no other concomitant surgery, and patients in the age range of 20 - 50 years. The first group received sublingual buprenorphine 6, 12, and 18 hours after the first administration. The second group received fentanyl as patient-controlled analgesia (PCA) for 24 hours. Then nausea, vomiting, sedation, and Visual Analog Scale (VAS) scores were evaluated at the beginning, 2, 6, 12, 18, and 24 hours after surgery. The collected data were analyzed using SPSS software version 20.
The mean age of the patients in the buprenorphine and fentanyl groups were 44.8 ± 5.5 and 42.8 ± 7.1 years, respectively. In this study, 22.5% of the patients in the buprenorphine group and 35.5% of the patients in the fentanyl group were male. During 6 and 24 hours after surgery, the pain level regarding the VAS scores was significantly lower in the buprenorphine group than in the fentanyl group; however, analgesic consumption was higher in the fentanyl group. In the early hours after surgery (2 and 6 hours), nausea and vomiting were lower in the buprenorphine group than in the fentanyl group even though the difference was not significant.
This study suggests buprenorphine as an effective drug for patients to reduce postoperative pain because of its limited complications, inexpensiveness, and more convenient administration method.
术后疼痛的恰当管理可改善患者生活质量,加速术后早期康复,缩短住院时间并降低医疗成本。本研究旨在比较静脉注射芬太尼泵与舌下含服丁丙诺啡片在开腹胆囊切除术后控制疼痛的效果。
评估舌下含服丁丙诺啡在减轻开腹胆囊切除术后疼痛及并发症方面的效果。
本研究为双盲随机临床试验。研究对象包括接受开腹胆囊切除术的患者、ASA分级为I级和II级的患者、未进行其他同期手术的个体以及年龄在20至50岁之间的患者。第一组在首次给药后6、12和18小时接受舌下含服丁丙诺啡。第二组接受芬太尼患者自控镇痛(PCA)24小时。然后在术后开始时、2、6、12、18和24小时评估恶心、呕吐、镇静及视觉模拟评分(VAS)。使用SPSS 20.0软件对收集的数据进行分析。
丁丙诺啡组和芬太尼组患者的平均年龄分别为44.8±5.5岁和42.8±7.1岁。本研究中,丁丙诺啡组22.5%的患者为男性,芬太尼组35.5%的患者为男性。术后6小时和24小时,丁丙诺啡组的VAS评分疼痛水平显著低于芬太尼组;然而,芬太尼组的镇痛药物消耗量更高。在术后早期(2小时和6小时),丁丙诺啡组的恶心和呕吐发生率低于芬太尼组,尽管差异不显著。
本研究表明,丁丙诺啡因其并发症有限、价格低廉且给药方法更便捷,是减轻患者术后疼痛的有效药物。